American Journal of Cardiology
Volume 104, Issue 4 , Pages 507-513 , 15 August 2009

Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry)

  • Matthew A. Cavender, MD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: (919) 684-8111; fax: (919) 681-6448
    • ,
  • Sarah Milford-Beland, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • William S. Weintraub, MD

      Affiliations

    • Christiana Care Health System, Newark, Delaware
    • ,
  • Sunil V. Rao, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina

Received 20 February 2009 ,Revised 2 April 2009 ,Accepted 2 April 2009.

References 

  1. Roe MT, Cura FA, Joski PS, Garcia E, Guetta V, Kereiakes DJ, et al. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol. 2001;88:170–173
  2. Corpus RA, House JA, Marso SP, Grantham JA, Huber KC, Laster SB, et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J. 2004;148:493–500
  3. Chen LY, Lennon RJ, Grantham JA, Berger PB, Mathew V, Singh M, et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am J Cardiol. 2005;95:349–354
  4. Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub WS, O'Neill WW, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians (National Cardiovascular Network Collaboration). J Am Coll Cardiol. 2000;36:723–730
  5. Singh M, Rihal CS, Gersh BJ, Lennon RJ, Prasad A, Sorajja P, et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation. 2007;115:2835–2841
  6. Varani E, Balducelli M, Aquilina M, Vecchi G, Hussien MN, Frassineti V, et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc Interv. 2008;72:927–933
  7. Weintraub WS, McKay CR, Riner RN, Ellis SG, Frommer PL, Carmichael DB, et al. The American College of Cardiology National Database: progress and challenges. J Am Coll Cardiol. 1997;29:459–465
  8. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol. 2001;37:2240–2245
  9. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588–636
  10. Xu F, Chen YG, Li JF, Li GS, Ji QS, Lv RJ, et al. Multivessel percutaneous coronary intervention in Chinese patients with acute myocardial infarction and simple nonculprit arteries. Am J Med Sci. 2007;333:376–380
  11. Katayama N, Horiuchi K, Nakao K, Kasanuki H, Honda T. [Does percutaneous coronary intervention in non-culprit vessels improve the prognosis of acute myocardial infarction complicated by pump failure?]. J Cardiol. 2005;46:1–8
  12. Qarawani D, Nahir M, Abboud M, Hazanov Y, Hasin Y. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol. 2007;123:288–292
  13. Khattab AA, Abdel-Wahab M, Rother C, Liska B, Toelg R, Kassner G, et al. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction: a single-center experience. Clin Res Cardiol. 2008;97:32–38
  14. Kalarus Z, Lenarczyk R, Kowalczyk J, Kowalski O, Gasior M, Was T, et al. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J. 2007;153:304–312
  15. Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPlprit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 2004;6:128–133
  16. Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, et al. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol. 2006;97:1585–1590
  17. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock). N Engl J Med. 1999;341:625–634
  18. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96:1200–1206
  19. Fokkema ML, Vlaar PJ, Svilaas T, Vogelzang M, Amo D, Diercks GF, et al. Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J. 2009;30:908–915
  20. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–2407

 This analysis was supported by a grant from the American College of Cardiology, Washington, DC, and the Society for Cardiac Angiography and Interventions, Washington, DC.

 This analysis was supported by the National Cardiovascular Data Registry.

 Dr. Roe was supported by research grants from Schering Plough, BMS/Sanofi-Aventis, KAI Pharmaceuticals, and DeCODE Genetics; is on the consulting/advisory boards for Schering Plough, KAI Pharmaceuticals; and is on the Speakers Bureau or has received honoraria from Schering Plough and BMS/Sanofi-Aventis.

 Dr. Peterson has received research grants from Bristol-Myers Squibb, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Bristol-Myers Squibb/Merck, and Schering (additional disclosure information for Dr. Peterson is available from: http://dcri.org/research/coi.jsp).

 Dr. Rao is a Consultant for Sanofi-Aventis and member of the Speakers' Bureaus for Sanofi-Aventis, Bristol Myers Squibb, and the Medicines Company and has received research funding from Momenta Pharmaceuticals, Portola Pharmaceuticals, and Cordis.

PII: S0002-9149(09)00919-9

doi: 10.1016/j.amjcard.2009.04.016

American Journal of Cardiology
Volume 104, Issue 4 , Pages 507-513 , 15 August 2009

Article Tools

* Image Usage & Resolution